VEGFA and retinopathy of prematurity: It suggested that anti-VEGF treatment neither reduced nor increased the occurrence of vascular abnormalities, and we agree with the authors that peripheral vascular abnormalities probably occur as a result of ROP itself rather than anti-VEGF treatment9,17.